Team

At Javelin Biotech, we are engineers, problem-solvers, and pioneers in the realm of microphysiological systems (MPS) and organ-on-chip (OoC) platforms.


With a rich history spanning over a decade and involvement in groundbreaking initiatives like DARPA Human Body on a Chip, NASA Tissue Chips in Space, and NIH NCATS Tissue Chip Testing Center, we have cultivated unparalleled expertise in our field. Leveraging this wealth of experience, we are dedicated to developing leading-edge technologies tailored specifically for the biopharmaceutical industry.

The Javelin Platform combines human tissue chips and digital twin software to predict how drugs will perform in humans, years before those therapeutic candidates are tested in clinical trials. From single-organ to multi-organ chips that use healthy and diseased tissues, we are building a portfolio of products to expand clients’ preclinical drug discovery capabilities to preclinical human models and AI-based translation to clinical insights, ultimately accelerating the process to bring safe and effective therapies to market faster than with existing tools and animal studies. 

This is Drug Discovery. Humanized.

Leadership

Murat Cirit, PhD

President and CEO, Cofounder

Kevin O’Handley, MBA

COO, Cofounder

Jacques Banchereau, PhD

CSO

Emily Geishecker, MS

VP of Operations, Cofounder

Shiny Rajan, PhD & MBA

Sr. Director of Tissue Engineering


Scientific Advisory Board

Donald Tweedie, PhD

Brian R. Berridge, DVM, PhD, DACVP

Adil Mardinoglu, PhD

Sanjiv Chopra, M.B.B.S., M.A.C.P.


Board of Directors

Venkat Srinivasan, PhD

Managing Director,
Innospark Ventures

Murat Cirit, PhD

President & CEO,
Javelin Biotech

Bill Emhiser, PhD

Former President, Millipore Life Sciences, Cofounder and Former CEO of Absolute Antibody, Kerafast

Ganesh Kaundinya, PhD

CEO of GlycoEra, Cofounder and Former CSO/COO of Momenta Pharmaceuticals


Investors

 
Javelin-Biotech_Innospark.png
Javelin-Biotech_Social-Starts.png